Gooal Gene Completes $1.4M Pre-A Round of Funding, Led by BGI Genomics

Recently, Gooal Gene has got tens of millions of yuan (US$1.4 million) in its Pre-A round of financing, led by BGI Genomics with participation from Rising Investments.

Proceeds of this financing will be used to develop breeding platform and application based on genomic analysis and big data, and promote the industrialization of genomic big data and molecular breeding technology with the support of BGI Genomics.

Gooal Gene is a biotechnology and Internet technology company focusing on molecular breeding and genomic big data. The company is committed to providing public research institutions and breeding enterprises with genomics big data analysis and interpretation, knowledge base and genomic selection breeding platform, and assisting researches in molecular breeding and genomic selection breeding of animal and plant.

This financing marks a milestone in the in-depth cooperation between Gooal Gene and BGI Genomics in the field of accurate breeding based on genomic big data. After the signing ceremony, the two companies made discussions on their future cooperation and unveiled the joint molecular breeding and sequencing laboratory together.

Gooal Gene will cooperate with BGI Genomics to explore genomic big data analysis and artificial intelligence, develop comprehensive solutions covering from gene sequencing to breeding program, and realize the goal of automatic and controllable molecular breeding technology.

Founded in 1999, BGI Genomics is one of the world's leading life science and genomics organizations. With businesses in more than 100 countries and regions around the world, it has established cooperation and partnerships with thousands of different organizations across multi-disciplinary research areas including medical health, resource conservation, and judicial services.

BGI Genomics provides equipment, technical support, and solutions for the needs of national economies and people's livelihoods, such as precision medicine and precision health. The company is committed to applying its genetic and technological achievements to real-world settings in order to realize the dream of trans-omics for a better life.

Founded in 2013, Rising Investments focuses on the investments in the field of new-generation information technology and advanced manufacturing, including artificial intelligence/big data, semiconductor, intelligent manufacturing, military equipment.